cordycepin has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K; Shinozuka, K; Yoshikawa, N | 1 |
| Liu, J; Luo, T; Qin, S; Song, G; Tian, H; Tian, X; Yao, S; Yu, Y; Zhao, Z | 1 |
1 review(s) available for cordycepin and Atherosclerosis
| Article | Year |
|---|---|
Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis.
Topics: Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Antineoplastic Agents; Atherosclerosis; Cell Line, Tumor; Cordyceps; Deoxyadenosines; Drug Therapy, Combination; Humans; Kupffer Cells; Medicine, Chinese Traditional; Methotrexate; Models, Biological; Neoplasm Metastasis; Pentostatin; Phytotherapy; Plant Extracts; Receptor, Adenosine A3; Signal Transduction | 2015 |
1 other study(ies) available for cordycepin and Atherosclerosis
| Article | Year |
|---|---|
Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
Topics: Animals; Antioxidants; Aorta; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Cholesterol; Cholesterol, HDL; Deoxyadenosines; Endothelium; Interleukin-1; Liver; Macrophages; Male; Malondialdehyde; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipid Transfer Proteins; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha | 2012 |